trending Market Intelligence /marketintelligence/en/news-insights/trending/ya6qg4peptv8flh8jgpcwg2 content esgSubNav
In This List

UniQure appoints 2 board members

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


UniQure appoints 2 board members

Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.

Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.